BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 23453369)

  • 1. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
    Luo M; Shen D; Zhou X; Chen X; Wang W
    Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.
    Wang N; Zhou Y; Zheng L; Li H
    Gynecol Oncol; 2014 Jul; 134(1):129-37. PubMed ID: 24793973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer.
    Xu J; Li Y; Wang F; Wang X; Cheng B; Ye F; Xie X; Zhou C; Lu W
    Oncogene; 2013 Feb; 32(8):976-87. PubMed ID: 22469983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells.
    Qiang R; Wang F; Shi LY; Liu M; Chen S; Wan HY; Li YX; Li X; Gao SY; Sun BC; Tang H
    Int J Biochem Cell Biol; 2011 Apr; 43(4):632-41. PubMed ID: 21216304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma.
    Wang YH; Han XD; Qiu Y; Xiong J; Yu Y; Wang B; Zhu ZZ; Qian BP; Chen YX; Wang SF; Shi HF; Sun X
    J Surg Oncol; 2012 Mar; 105(3):235-43. PubMed ID: 21866554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor.
    Zhao X; Dou W; He L; Liang S; Tie J; Liu C; Li T; Lu Y; Mo P; Shi Y; Wu K; Nie Y; Fan D
    Oncogene; 2013 Mar; 32(11):1363-72. PubMed ID: 22614005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling.
    Shen MR; Hsu YM; Hsu KF; Chen YF; Tang MJ; Chou CY
    Carcinogenesis; 2006 May; 27(5):962-71. PubMed ID: 16400188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-590 promotes cervical cancer cell growth and invasion by targeting CHL1.
    Chu Y; Ouyang Y; Wang F; Zheng A; Bai L; Han L; Chen Y; Wang H
    J Cell Biochem; 2014 May; 115(5):847-53. PubMed ID: 24288179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines.
    Nakamura K; Hongo A; Kodama J; Miyagi Y; Yoshinouchi M; Kudo T
    Cancer Res; 2000 Feb; 60(3):760-5. PubMed ID: 10676665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-196a targets netrin 4 and regulates cell proliferation and migration of cervical cancer cells.
    Zhang J; Zheng F; Yu G; Yin Y; Lu Q
    Biochem Biophys Res Commun; 2013 Nov; 440(4):582-8. PubMed ID: 24120501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab.
    Nishida N; Mimori K; Fabbri M; Yokobori T; Sudo T; Tanaka F; Shibata K; Ishii H; Doki Y; Mori M
    Clin Cancer Res; 2011 May; 17(9):2725-33. PubMed ID: 21220473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
    Xu M; Gu M; Zhang K; Zhou J; Wang Z; Da J
    Diagn Pathol; 2015 Apr; 10():24. PubMed ID: 25890121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-145 directly targets the insulin-like growth factor receptor I in human bladder cancer cells.
    Zhu Z; Xu T; Wang L; Wang X; Zhong S; Xu C; Shen Z
    FEBS Lett; 2014 Aug; 588(17):3180-5. PubMed ID: 24999188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulated expression of miR-145 in manifold human cancer cells.
    Xing AY; Wang B; Shi DB; Zhang XF; Gao C; He XQ; Liu WJ; Gao P
    Exp Mol Pathol; 2013 Aug; 95(1):91-7. PubMed ID: 23714355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells.
    Long MJ; Wu FX; Li P; Liu M; Li X; Tang H
    Cancer Lett; 2012 Nov; 324(2):186-96. PubMed ID: 22634495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.
    Pang RT; Leung CO; Ye TM; Liu W; Chiu PC; Lam KK; Lee KF; Yeung WS
    Carcinogenesis; 2010 Jun; 31(6):1037-44. PubMed ID: 20351093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.
    Cao S; Liu W; Li F; Zhao W; Qin C
    Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid regulation of a novel HPV-E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells.
    Shi M; Du L; Liu D; Qian L; Hu M; Yu M; Yang Z; Zhao M; Chen C; Guo L; Wang L; Song L; Ma Y; Guo N
    J Pathol; 2012 Oct; 228(2):148-57. PubMed ID: 22287315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential expression of miR-21, miR-126, miR-143, miR-373 in normal cervical tissue, cervical cancer tissue and Hela cell].
    Liu L; Wang YL; Wang JF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 43(4):536-9. PubMed ID: 22997891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-26a inhibits cell proliferation and invasion of cervical cancer cells by targeting protein tyrosine phosphatase type IVA 1.
    Dong J; Sui L; Wang Q; Chen M; Sun H
    Mol Med Rep; 2014 Sep; 10(3):1426-32. PubMed ID: 24939702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.